Skip to main content
Premium Trial:

Request an Annual Quote

Verify Diagnostics Rapid Coronavirus Antibody Test Gets Canadian Authorization

NEW YORK — Verify Diagnostics said on Tuesday that it has received authorization from Canadian regulators for its Assure Tech Ecotest COVID-19 serological rapid test for SARS-CoV-2 infection.

According to the Ontario-based company, the point-of-care test is designed to detect antibodies against SARS-CoV-2 in a fingerstick blood sample.

"Antibody testing is key to understanding the prevalence of COVID-19 in our Canadian communities and, although complicated laboratory solutions are available to accomplish this, rapid testing offers an easy and inexpensive option to healthcare professionals and public health organizations," Verify CEO Tim Salter said in a statement.